Header Logo

Connection

Lawrence Kushi to Breast Neoplasms

Back to Details
This is a "connection" page, showing publications Lawrence Kushi has written about Breast Neoplasms.
Lawrence Kushi
Connection Strength
13.778
Breast Neoplasms
  1. Social Support and Treatment Delays in Breast Cancer Patients Within an Integrated Health Care System. Psychooncology. 2024 Nov; 33(11):e70025.
    View in: PubMed
    Score: 0.548
  2. Clinical, Epidemiologic, and Pathologic Significance of ERBB2-Low Expression in Breast Cancer. JAMA Netw Open. 2024 Mar 04; 7(3):e243345.
    View in: PubMed
    Score: 0.523
  3. Associations of Post-Diagnosis Lifestyle with Prognosis in Women with Invasive Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2023 07 05; 32(7):963-975.
    View in: PubMed
    Score: 0.500
  4. Management of ovarian and breast cancer risk in non-BRCA HBOC pathogenic variant carriers in a large California health care system. Gynecol Oncol. 2022 Dec; 167(3):467-475.
    View in: PubMed
    Score: 0.475
  5. "I Had to Make Them Feel at Ease": Narrative Accounts of How Women With Breast Cancer Navigate Social Support. Qual Health Res. 2021 05; 31(6):1056-1068.
    View in: PubMed
    Score: 0.425
  6. Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system. Breast Cancer Res Treat. 2018 Aug; 170(3):623-631.
    View in: PubMed
    Score: 0.348
  7. Understanding racial/ethnic differences in breast cancer-related physical well-being: the role of patient-provider interactions. Breast Cancer Res Treat. 2018 Aug; 170(3):593-603.
    View in: PubMed
    Score: 0.347
  8. Vitamin D and Breast Cancer Survival-In Reply. JAMA Oncol. 2017 08 01; 3(8):1139-1140.
    View in: PubMed
    Score: 0.331
  9. Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival: A Case-Cohort Analysis in the Pathways Study. JAMA Oncol. 2017 Mar 01; 3(3):351-357.
    View in: PubMed
    Score: 0.322
  10. BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study. J Natl Cancer Inst. 2017 02; 109(2).
    View in: PubMed
    Score: 0.314
  11. Representativeness of breast cancer cases in an integrated health care delivery system. BMC Cancer. 2015 Oct 14; 15:688.
    View in: PubMed
    Score: 0.293
  12. Preliminary Development and Evaluation of an Algorithm to Identify Breast Cancer Chemotherapy Toxicities Using Electronic Medical Records and Administrative Data. J Oncol Pract. 2015 01; 11(1):e1-8.
    View in: PubMed
    Score: 0.270
  13. Changes in vitamin and mineral supplement use after breast cancer diagnosis in the Pathways Study: a prospective cohort study. BMC Cancer. 2014 May 29; 14:382.
    View in: PubMed
    Score: 0.266
  14. Patient-physician interaction and quality of life in recently diagnosed breast cancer patients. Breast Cancer Res Treat. 2013 Jun; 139(2):581-95.
    View in: PubMed
    Score: 0.248
  15. Social networks, social support mechanisms, and quality of life after breast cancer diagnosis. Breast Cancer Res Treat. 2013 Jun; 139(2):515-27.
    View in: PubMed
    Score: 0.247
  16. Employment status and quality of life in recently diagnosed breast cancer survivors. Psychooncology. 2013 Jun; 22(6):1411-20.
    View in: PubMed
    Score: 0.235
  17. Validation of AJCC TNM staging for breast tumors diagnosed before 2004 in cancer registries. Cancer Causes Control. 2012 Sep; 23(9):1587-91.
    View in: PubMed
    Score: 0.234
  18. Change in physical activity during active treatment in a prospective study of breast cancer survivors. Breast Cancer Res Treat. 2012 Jan; 131(2):679-90.
    View in: PubMed
    Score: 0.221
  19. Associations of physical activity with quality of life and functional ability in breast cancer patients during active adjuvant treatment: the Pathways Study. Breast Cancer Res Treat. 2011 Sep; 129(2):521-9.
    View in: PubMed
    Score: 0.214
  20. Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study. Arch Surg. 2010 Nov; 145(11):1055-63.
    View in: PubMed
    Score: 0.208
  21. Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study. Breast Cancer Res Treat. 2010 Sep; 123(2):507-24.
    View in: PubMed
    Score: 0.197
  22. Complementary and alternative therapy use before and after breast cancer diagnosis: the Pathways Study. Breast Cancer Res Treat. 2009 Oct; 117(3):653-65.
    View in: PubMed
    Score: 0.184
  23. The Pathways Study: a prospective study of breast cancer survivorship within Kaiser Permanente Northern California. Cancer Causes Control. 2008 Dec; 19(10):1065-76.
    View in: PubMed
    Score: 0.175
  24. Lifestyle factors and survival in women with breast cancer. J Nutr. 2007 01; 137(1 Suppl):236S-242S.
    View in: PubMed
    Score: 0.159
  25. Adherence to cardiovascular medications and risk of cardiovascular disease in breast cancer patients: A causal inference approach in the Pathways Heart Study. PLoS One. 2024; 19(9):e0310531.
    View in: PubMed
    Score: 0.136
  26. The landscape of use of NCCN-guideline chemotherapy regimens in stage I-IIIA breast cancer in an integrated healthcare delivery system. Breast Cancer Res Treat. 2024 Nov; 208(2):405-414.
    View in: PubMed
    Score: 0.135
  27. Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019. Breast Cancer Res. 2024 Jun 13; 26(1):101.
    View in: PubMed
    Score: 0.133
  28. Methodology for Using Real-World Data From Electronic Health Records to Assess Chemotherapy Administration in Women With Breast Cancer. JCO Clin Cancer Inform. 2024 Apr; 8:e2300209.
    View in: PubMed
    Score: 0.131
  29. Diet quality and cardiovascular disease risk among breast cancer survivors in the Pathways Study. JNCI Cancer Spectr. 2024 Feb 29; 8(2).
    View in: PubMed
    Score: 0.131
  30. Risk of adverse birth outcomes after adolescent and young adult cancer. JNCI Cancer Spectr. 2024 Jan 04; 8(1).
    View in: PubMed
    Score: 0.129
  31. A Mendelian Randomization Analysis of 55 Genetically Predicted Metabolic Traits with Breast Cancer Survival Outcomes in the Pathways Study. Cancer Res Commun. 2023 06; 3(6):1104-1112.
    View in: PubMed
    Score: 0.125
  32. Development of cardiometabolic risk factors following endocrine therapy in women with breast cancer. Breast Cancer Res Treat. 2023 Aug; 201(1):117-126.
    View in: PubMed
    Score: 0.124
  33. Comparison of Mammography AI Algorithms with a Clinical Risk Model for 5-year Breast Cancer Risk Prediction: An Observational Study. Radiology. 2023 06; 307(5):e222733.
    View in: PubMed
    Score: 0.124
  34. Neighborhood attributes and cardiovascular disease risk in breast cancer survivors: The Pathways Study. Cancer. 2023 08 01; 129(15):2395-2408.
    View in: PubMed
    Score: 0.123
  35. Results and lessons from dual extraction of DNA and RNA from formalin-fixed paraffin-embedded breast tumor tissues for a large Cancer epidemiologic study. BMC Genomics. 2022 Aug 25; 23(1):614.
    View in: PubMed
    Score: 0.118
  36. Telehealth for Preoperative Evaluation of Patients With Breast Cancer During the COVID-19 Pandemic. Perm J. 2022 06 29; 26(2):54-63.
    View in: PubMed
    Score: 0.116
  37. Risk of heart failure with preserved versus reduced ejection fraction in women with breast cancer. Breast Cancer Res Treat. 2022 Jun; 193(3):669-675.
    View in: PubMed
    Score: 0.115
  38. Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study. J Clin Oncol. 2022 May 20; 40(15):1647-1658.
    View in: PubMed
    Score: 0.115
  39. Modeling risks of cardiovascular and cancer mortality following a diagnosis of loco-regional breast cancer. Breast Cancer Res. 2021 09 27; 23(1):91.
    View in: PubMed
    Score: 0.110
  40. Plant-Based Dietary Patterns and Breast Cancer Recurrence and Survival in the Pathways Study. Nutrients. 2021 Sep 25; 13(10).
    View in: PubMed
    Score: 0.110
  41. Cross-ancestry GWAS meta-analysis identifies six breast cancer loci in African and European ancestry women. Nat Commun. 2021 07 07; 12(1):4198.
    View in: PubMed
    Score: 0.109
  42. A Polygenic Risk Score for Breast Cancer in US Latinas and Latin American Women. J Natl Cancer Inst. 2020 06 01; 112(6):590-598.
    View in: PubMed
    Score: 0.101
  43. Physical activity and incidence of postmenopausal breast cancer. Epidemiology. 2000 May; 11(3):292-6.
    View in: PubMed
    Score: 0.100
  44. Distinct trajectories of moderate to vigorous physical activity and sedentary behavior following a breast cancer diagnosis: the Pathways Study. J Cancer Surviv. 2020 06; 14(3):393-403.
    View in: PubMed
    Score: 0.099
  45. Adjuvant endocrine therapy for breast cancer patients: impact of a health system outreach program to improve adherence. Breast Cancer Res Treat. 2020 Feb; 180(1):219-226.
    View in: PubMed
    Score: 0.098
  46. Serum bone markers and risk of osteoporosis and fragility fractures in women who received endocrine therapy for breast cancer: a prospective study. Breast Cancer Res Treat. 2020 Feb; 180(1):187-195.
    View in: PubMed
    Score: 0.098
  47. Is Breast Cancer in Asian and Asian American Women a Different Disease? J Natl Cancer Inst. 2019 12 01; 111(12):1243-1244.
    View in: PubMed
    Score: 0.097
  48. Distinct trajectories of fruits and vegetables, dietary fat, and alcohol intake following a breast cancer diagnosis: the Pathways Study. Breast Cancer Res Treat. 2020 Jan; 179(1):229-240.
    View in: PubMed
    Score: 0.096
  49. Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy. Breast Cancer Res Treat. 2018 Apr; 168(2):523-530.
    View in: PubMed
    Score: 0.085
  50. Childhood Socioeconomic Position and Pubertal Onset in a Cohort of Multiethnic Girls: Implications for Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2017 12; 26(12):1714-1721.
    View in: PubMed
    Score: 0.084
  51. Genetic Ancestry Is not Associated with Breast Cancer Recurrence or Survival in U.S. Latina Women Enrolled in the Kaiser Permanente Pathways Study. Cancer Epidemiol Biomarkers Prev. 2017 09; 26(9):1466-1469.
    View in: PubMed
    Score: 0.083
  52. Patterns and reasons for switching classes of hormonal therapy among women with early-stage breast cancer. Cancer Causes Control. 2017 Jun; 28(6):557-562.
    View in: PubMed
    Score: 0.081
  53. Body mass index, PAM50 subtype, recurrence, and survival among patients with nonmetastatic breast cancer. Cancer. 2017 Jul 01; 123(13):2535-2542.
    View in: PubMed
    Score: 0.081
  54. Adiposity, post-diagnosis weight change, and risk of cardiovascular events among early-stage breast cancer survivors. Breast Cancer Res Treat. 2017 04; 162(3):549-557.
    View in: PubMed
    Score: 0.080
  55. Impact of Social and Built Environment Factors on Body Size among Breast Cancer Survivors: The Pathways Study. Cancer Epidemiol Biomarkers Prev. 2017 04; 26(4):505-515.
    View in: PubMed
    Score: 0.080
  56. Bone remodeling and regulating biomarkers in women at the time of breast cancer diagnosis. Breast Cancer Res Treat. 2017 02; 161(3):501-513.
    View in: PubMed
    Score: 0.079
  57. Association Between Complementary and Alternative Medicine Use and Breast Cancer Chemotherapy Initiation: The Breast Cancer Quality of Care (BQUAL) Study. JAMA Oncol. 2016 Sep 01; 2(9):1170-6.
    View in: PubMed
    Score: 0.078
  58. Exercise and Prognosis on the Basis of Clinicopathologic and Molecular Features in Early-Stage Breast Cancer: The LACE and Pathways Studies. Cancer Res. 2016 09 15; 76(18):5415-22.
    View in: PubMed
    Score: 0.077
  59. Intake of vitamins A, C, and E and postmenopausal breast cancer. The Iowa Women's Health Study. Am J Epidemiol. 1996 Jul 15; 144(2):165-74.
    View in: PubMed
    Score: 0.077
  60. A prospective cohort study of early discontinuation of adjuvant chemotherapy in women with breast cancer: the breast cancer quality of care study (BQUAL). Breast Cancer Res Treat. 2016 07; 158(1):127-138.
    View in: PubMed
    Score: 0.077
  61. Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer. J Clin Oncol. 2016 08 10; 34(23):2743-9.
    View in: PubMed
    Score: 0.076
  62. Breast cancer multigene testing trends and impact on chemotherapy use. Am J Manag Care. 2016 05 01; 22(5):e153-60.
    View in: PubMed
    Score: 0.076
  63. Psychosocial factors related to non-persistence with adjuvant endocrine therapy among women with breast cancer: the Breast Cancer Quality of Care Study (BQUAL). Breast Cancer Res Treat. 2016 05; 157(1):133-43.
    View in: PubMed
    Score: 0.076
  64. Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival. J Natl Cancer Inst. 2015 Jul; 107(7).
    View in: PubMed
    Score: 0.071
  65. Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression. BMC Cancer. 2015 Apr 14; 15:278.
    View in: PubMed
    Score: 0.071
  66. Dietary fat and risk of breast cancer according to hormone receptor status. Cancer Epidemiol Biomarkers Prev. 1995 Jan-Feb; 4(1):11-9.
    View in: PubMed
    Score: 0.069
  67. Bone health history in breast cancer patients on aromatase inhibitors. PLoS One. 2014; 9(10):e111477.
    View in: PubMed
    Score: 0.068
  68. A multilevel model of postmenopausal breast cancer incidence. Cancer Epidemiol Biomarkers Prev. 2014 Oct; 23(10):2078-92.
    View in: PubMed
    Score: 0.067
  69. Non-initiation and early discontinuation of adjuvant trastuzumab in women with localized HER2-positive breast cancer. Breast Cancer. 2014 Nov; 21(6):780-5.
    View in: PubMed
    Score: 0.067
  70. Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression. Breast Cancer Res Treat. 2014 Apr; 144(3):689-99.
    View in: PubMed
    Score: 0.065
  71. Intrinsic subtypes from PAM50 gene expression assay in a population-based breast cancer cohort: differences by age, race, and tumor characteristics. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):714-24.
    View in: PubMed
    Score: 0.065
  72. Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short- and long-term outcomes. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):725-34.
    View in: PubMed
    Score: 0.065
  73. Racial disparities in posttraumatic stress after diagnosis of localized breast cancer: the BQUAL study. J Natl Cancer Inst. 2013 Apr 17; 105(8):563-72.
    View in: PubMed
    Score: 0.061
  74. Familial clustering of colon, breast, uterine, and ovarian cancers as assessed by family history. Genet Epidemiol. 1993; 10(4):235-44.
    View in: PubMed
    Score: 0.060
  75. Interpersonal influences and attitudes about adjuvant therapy treatment decisions among non-metastatic breast cancer patients: an examination of differences by age and race/ethnicity in the BQUAL study. Breast Cancer Res Treat. 2013 Feb; 137(3):817-28.
    View in: PubMed
    Score: 0.060
  76. Patterns and predictors of breast cancer chemotherapy use in Kaiser Permanente Northern California, 2004-2007. Breast Cancer Res Treat. 2013 Jan; 137(1):247-60.
    View in: PubMed
    Score: 0.060
  77. A survey of breast cancer physicians regarding patient involvement in breast cancer treatment decisions. Breast. 2013 Aug; 22(4):548-54.
    View in: PubMed
    Score: 0.060
  78. Noninitiation of adjuvant chemotherapy in women with localized breast cancer: the breast cancer quality of care study. J Clin Oncol. 2012 Nov 01; 30(31):3800-9.
    View in: PubMed
    Score: 0.059
  79. Dietary fat and postmenopausal breast cancer. J Natl Cancer Inst. 1992 Jul 15; 84(14):1092-9.
    View in: PubMed
    Score: 0.058
  80. Non-initiation of adjuvant hormonal therapy in women with hormone receptor-positive breast cancer: The Breast Cancer Quality of Care Study (BQUAL). Breast Cancer Res Treat. 2012 Jul; 134(1):419-28.
    View in: PubMed
    Score: 0.057
  81. The Breast Cancer Quality of Care Study (BQUAL): a multi-center study to determine causes for noncompliance with breast cancer adjuvant therapy. Breast J. 2012 May-Jun; 18(3):203-13.
    View in: PubMed
    Score: 0.057
  82. Antioxidant supplement use after breast cancer diagnosis and mortality in the Life After Cancer Epidemiology (LACE) cohort. Cancer. 2012 Apr 15; 118(8):2048-58.
    View in: PubMed
    Score: 0.055
  83. Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer. Breast Cancer Res Treat. 2012 Jan; 131(2):607-17.
    View in: PubMed
    Score: 0.055
  84. Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology study. Breast Cancer Res Treat. 2011 Nov; 130(1):195-205.
    View in: PubMed
    Score: 0.054
  85. A practical method for collecting food record data in a prospective cohort study of breast cancer survivors. Am J Epidemiol. 2010 Dec 01; 172(11):1315-23.
    View in: PubMed
    Score: 0.052
  86. Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol. 2010 Oct 10; 28(29):4410-6.
    View in: PubMed
    Score: 0.051
  87. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat. 2011 Apr; 126(2):529-37.
    View in: PubMed
    Score: 0.051
  88. Breast cancer DNA methylation profiles are associated with tumor size and alcohol and folate intake. PLoS Genet. 2010 Jul 29; 6(7):e1001043.
    View in: PubMed
    Score: 0.051
  89. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol. 2010 Sep 20; 28(27):4120-8.
    View in: PubMed
    Score: 0.051
  90. Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res. 2009; 11(3):R31.
    View in: PubMed
    Score: 0.047
  91. Dietary patterns and breast cancer recurrence and survival among women with early-stage breast cancer. J Clin Oncol. 2009 Feb 20; 27(6):919-26.
    View in: PubMed
    Score: 0.046
  92. Aspects of the rationale for the Women's Health Trial. J Natl Cancer Inst. 1988 Aug 03; 80(11):802-14.
    View in: PubMed
    Score: 0.044
  93. Re: Declines in invasive breast cancer and use of postmenopausal hormone therapy in a screening mammography population. J Natl Cancer Inst. 2008 Apr 16; 100(8):597-8; author reply 599.
    View in: PubMed
    Score: 0.043
  94. Dietary patterns and breast density in the Minnesota Breast Cancer Family Study. Cancer Causes Control. 2008 Jun; 19(5):481-9.
    View in: PubMed
    Score: 0.043
  95. Mediterranean diet and breast density in the Minnesota Breast Cancer Family Study. Nutr Cancer. 2008; 60(6):703-9.
    View in: PubMed
    Score: 0.043
  96. Recent declines in hormone therapy utilization and breast cancer incidence: clinical and population-based evidence. J Clin Oncol. 2006 Nov 20; 24(33):e49-50.
    View in: PubMed
    Score: 0.039
  97. Body size changes in relation to postmenopausal breast cancer among women on Long Island, New York. Am J Epidemiol. 2005 Aug 01; 162(3):229-37.
    View in: PubMed
    Score: 0.036
  98. Dietary fat and cancer. Am J Med. 2002 Dec 30; 113 Suppl 9B:63S-70S.
    View in: PubMed
    Score: 0.030
  99. Interaction of dietary folate intake, alcohol, and risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women. Cancer Epidemiol Biomarkers Prev. 2002 Oct; 11(10 Pt 1):1104-7.
    View in: PubMed
    Score: 0.030
  100. Meat and dairy food consumption and breast cancer: a pooled analysis of cohort studies. Int J Epidemiol. 2002 Feb; 31(1):78-85.
    View in: PubMed
    Score: 0.028
  101. High-folate diets and breast cancer survival in a prospective cohort study. Nutr Cancer. 2002; 44(2):139-44.
    View in: PubMed
    Score: 0.028
  102. Population-based case-control study of soyfood intake and breast cancer risk in Shanghai. Br J Cancer. 2001 Aug 03; 85(3):372-8.
    View in: PubMed
    Score: 0.027
  103. Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women. Epidemiology. 2001 Jul; 12(4):420-8.
    View in: PubMed
    Score: 0.027
  104. Types of dietary fat and breast cancer: a pooled analysis of cohort studies. Int J Cancer. 2001 Jun 01; 92(5):767-74.
    View in: PubMed
    Score: 0.027
  105. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol Biomarkers Prev. 2001 May; 10(5):483-8.
    View in: PubMed
    Score: 0.027
  106. Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol. 2000 Sep 15; 152(6):514-27.
    View in: PubMed
    Score: 0.026
  107. Association of menstrual and reproductive factors with breast cancer risk: results from the Shanghai Breast Cancer Study. Int J Cancer. 2000 Jul 15; 87(2):295-300.
    View in: PubMed
    Score: 0.025
  108. Twinship and risk of postmenopausal breast cancer. J Natl Cancer Inst. 2000 Feb 02; 92(3):261-5.
    View in: PubMed
    Score: 0.025
  109. Association of diet and mammographic breast density in the Minnesota breast cancer family cohort. Cancer Epidemiol Biomarkers Prev. 2000 Feb; 9(2):151-60.
    View in: PubMed
    Score: 0.025
  110. Fifty-year follow-up of cancer incidence in a historical cohort of Minnesota breast cancer families. Cancer Epidemiol Biomarkers Prev. 1999 Dec; 8(12):1051-7.
    View in: PubMed
    Score: 0.024
  111. Inclusion of risk factor covariates in a segregation analysis of a population-based sample of 426 breast cancer families. Genet Epidemiol. 1999; 16(2):150-64.
    View in: PubMed
    Score: 0.023
  112. Well-done meat intake and the risk of breast cancer. J Natl Cancer Inst. 1998 Nov 18; 90(22):1724-9.
    View in: PubMed
    Score: 0.023
  113. The role of hormone replacement therapy in the risk for breast cancer and total mortality in women with a family history of breast cancer. Ann Intern Med. 1997 Dec 01; 127(11):973-80.
    View in: PubMed
    Score: 0.021
  114. Non-dietary factors as risk factors for breast cancer, and as effect modifiers of the association of fat intake and risk of breast cancer. Cancer Causes Control. 1997 Jan; 8(1):49-56.
    View in: PubMed
    Score: 0.020
  115. Evaluation of potential sources of bias in a genetic epidemiologic study of breast cancer. Genet Epidemiol. 1997; 14(1):85-95.
    View in: PubMed
    Score: 0.020
  116. Segregation analysis of breast cancer: a comparison of type-dependent age-at-onset versus type-dependent susceptibility models. Genet Epidemiol. 1996; 13(4):317-28.
    View in: PubMed
    Score: 0.019
  117. Better breast cancer survival for postmenopausal women who are less overweight and eat less fat. The Iowa Women's Health Study. Cancer. 1995 Jul 15; 76(2):275-83.
    View in: PubMed
    Score: 0.018
  118. Epidemiologic and genetic follow-up study of 544 Minnesota breast cancer families: design and methods. Genet Epidemiol. 1995; 12(4):417-29.
    View in: PubMed
    Score: 0.017
  119. Familial clustering of breast and prostate cancers and risk of postmenopausal breast cancer. J Natl Cancer Inst. 1994 Dec 21; 86(24):1860-5.
    View in: PubMed
    Score: 0.017
  120. Dietary predictors of urinary environmental biomarkers in young girls, BCERP, 2004-7. Environ Res. 2014 Aug; 133:12-9.
    View in: PubMed
    Score: 0.017
  121. Association of body fat distribution and family histories of breast and ovarian cancer with risk of postmenopausal breast cancer. Am J Epidemiol. 1993 Nov 15; 138(10):799-803.
    View in: PubMed
    Score: 0.016
  122. No association between caffeine intake and postmenopausal breast cancer incidence in the Iowa Women's Health Study. Am J Epidemiol. 1993 Sep 15; 138(6):380-3.
    View in: PubMed
    Score: 0.016
  123. Difficulty becoming pregnant and family history as interactive risk factors for postmenopausal breast cancer: the Iowa Women's Health Study. Cancer Causes Control. 1993 Jan; 4(1):21-8.
    View in: PubMed
    Score: 0.015
  124. Effect of family history, body-fat distribution, and reproductive factors on the risk of postmenopausal breast cancer. N Engl J Med. 1992 May 14; 326(20):1323-9.
    View in: PubMed
    Score: 0.014
  125. Feasibility of a randomized trial of a low-fat diet for the prevention of breast cancer: dietary compliance in the Women's Health Trial Vanguard Study. Prev Med. 1990 Mar; 19(2):115-33.
    View in: PubMed
    Score: 0.012
  126. Association of childhood and adolescent anthropometric factors, physical activity, and diet with adult mammographic breast density. Am J Epidemiol. 2007 Aug 15; 166(4):456-64.
    View in: PubMed
    Score: 0.010

© 2025 Kaiser Permanente